| Literature DB >> 32700771 |
Walid Haouari1, Johanne Dubail2, Samra Lounis-Ouaras1,3, Pierre Prada4, Rizk Bennani4, Charles Roseau1, Céline Huber2, Alexandra Afenjar5, Estelle Colin6,7, Sandrine Vuillaumier-Barrot4, Nathalie Seta4,8, François Foulquier9, Christian Poüs1,3, Valérie Cormier-Daire2, Arnaud Bruneel1,4.
Abstract
Bikunin (Bkn) isoforms are serum chondroitin sulfate (CS) proteoglycans synthesized by the liver. They include two light forms, that is, the Bkn core protein and the Bkn linked to the CS chain (urinary trypsin inhibitor [UTI]), and two heavy forms, that is, pro-α-trypsin inhibitor and inter-α-trypsin inhibitor, corresponding to UTI esterified by one or two heavy chains glycoproteins, respectively. We previously showed that the Western-blot analysis of the light forms could allow the fast and easy detection of patients with linkeropathy, deficient in enzymes involved in the synthesis of the initial common tetrasaccharide linker of glycosaminoglycans. Here, we analyzed all serum Bkn isoforms in a context of congenital disorders of glycosylation (CDG) and showed very specific abnormal patterns suggesting potential interests for their screening and diagnosis. In particular, genetic deficiencies in V-ATPase (ATP6V0A2-CDG, CCDC115-CDG, ATP6AP1-CDG), in Golgi manganese homeostasis (TMEM165-CDG) and in the N-acetyl-glucosamine Golgi transport (SLC35A3-CDG) all share specific abnormal Bkn patterns. Furthermore, for each studied linkeropathy, we show that the light abnormal Bkn could be further in-depth characterized by two-dimensional electrophoresis. Moreover, besides being interesting as a specific biomarker of both CDG and linkeropathies, Bkn isoforms' analyses can provide new insights into the pathophysiology of the aforementioned diseases.Entities:
Keywords: CDG; GAG tetrasaccharide; SLC35A3; TMEM165; bikunin; inter-α-trypsin inhibitor; linkeropathies
Year: 2020 PMID: 32700771 DOI: 10.1002/jimd.12291
Source DB: PubMed Journal: J Inherit Metab Dis ISSN: 0141-8955 Impact factor: 4.982